AzTrials
AzTrials

Self EsteemIMPOSTOR-2025NCT07725302

Correlates of Imposter Syndrome Among Indonesian Sports Science Students

An observational study of Self Esteem and Anxiety, run by Hasanuddin University at 1 site in Indonesia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This cross-sectional study was conducted from June to August 2025 among sports science undergraduates at State University of Makassar, South Sulawesi, Indonesia, following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Read more about this study

Who is it for?
Any ageHealthy volunteers can take part
Conditions the study is for
Self Esteem, Anxiety, Imposter Syndrome
What is being tested?
Self-Report Questionnaire Assessment
How many people
438 participants
Where
1 siteIndonesia
Study dates
1 Jun 2025to 31 Aug 2025
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Study population: Sports science undergraduate students enrolled in semesters three or four at State University of Makassar, South Sulawesi, Indonesia.

Eligible participants were active undergraduate students enrolled in semesters 3 or 4 of the sports science program at State University of Makassar, South Sulawesi, Indonesia, with adequate Bahasa Indonesia proficiency, willingness to be contacted, and provision of written informed consent; students were excluded for ineligible semester, insufficient Bahasa Indonesia proficiency, unwillingness to be contacted, incomplete survey responses, refusal of consent, treated psychiatric disorder, or documented history of substance use disorder.

Trial locations and contacts

1 site in 1 country.

Indonesia1 site
  • Department of Psychiatry, Faculty of Medicine, Hasanuddin University, Jl. Perintis Kemerdekaan KM. 10, Tamalanrea Makassar 90245, South Sulawesi, Indonesia

    Makassar, South Sulawesi, 90245

Other trials in Indonesia

About this study

Official title: The Contributions of Anxiety and Self-Esteem to Imposter Syndrome Among Sports Science Undergraduates in Indonesia: A Cross-Sectional Survey

This cross-sectional study was conducted from June to August 2025 among sports science undergraduates at State University of Makassar, South Sulawesi, Indonesia, following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Ethical clearance was granted by the Institutional Biomedical Research Ethics Committee of Hasanuddin University (PROTOKOL-UH25010017), procedures followed the 2013 Declaration of Helsinki, and written informed consent was obtained from every participant.

NOTE: This study was retrospectively registered. The study was conducted from June 2025 to August 2025 following the STROBE guidelines and received ethical clearance from the Institutional Biomedical Research Ethics Committee of Hasanuddin University prior to study initiation. Written informed consent was obtained from all participants. No outcome measures, study design, or statistical analysis plan were modified following data collection.

Read the detailed description

BACKGROUND:

Imposter syndrome, characterized by a persistent sense of intellectual phoniness and pervasive fear of exposure despite objective evidence of competence, is well documented among undergraduate populations yet remains understudied among non-medical Southeast Asian students, particularly within sports science and related health disciplines.

STUDY DESIGN AND PARTICIPANTS:

This cross-sectional study was conducted from June to August 2025 among sports science undergraduates at State University of Makassar, South Sulawesi, Indonesia, following the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines. Ethical clearance was granted by the Institutional Biomedical Research Ethics Committee of Hasanuddin University (PROTOKOL-UH25010017), and all procedures were conducted in accordance with the 2013 Declaration of Helsinki. Written informed consent was obtained from every participant, who could withdraw at any time without consequence, and no identifying information was disclosed. The master dataset comprised 438 respondents. Fifteen had genuine missing cumulative GPA values. Analyses not involving GPA, including descriptive, reliability, non-GPA correlation, and non-GPA group-comparison analyses, used N = 438. The GPA correlation, GPA-category comparison, simultaneous ordinary least squares regression, Huber M-estimation, median quantile regression, and hierarchical regression models used the same 423 complete cases under listwise deletion. Eligible students in semesters 3 and 4 were approached during scheduled in-person classes using a mixed paper and online administration procedure, rather than the single supervised classroom administration originally registered with ClinicalTrials.gov. Students could complete a paper-based questionnaire immediately during the class break or within 48 hours; alternatively, they could complete an equivalent online version distributed via the official student communication platform. Two reminder messages were sent at 7-day intervals to non-respondents. No monetary or academic incentives were provided for participation. Data were collected using the Rosenberg Self-Esteem Scale (RSES), the Generalized Anxiety Disorder-7 (GAD-7) scale, and the Clance Impostor Phenomenon Scale (CIPS). The analyses included Spearman's rank correlations, Mann-Whitney U tests, simultaneous ordinary least squares regression, hierarchical multiple linear regression, Huber M-estimation, and median quantile regression at τ = 0.50. The analyses identified adjusted associations rather than causal or predictive relationships, consistent with the cross-sectional design.

MEASURES AND INSTRUMENTS:

Self-esteem, anxiety, and imposter syndrome were assessed using the Rosenberg Self-Esteem Scale (RSES), the Generalized Anxiety Disorder-7 (GAD-7) scale, and the Clance Impostor Phenomenon Scale (CIPS), respectively. The RSES consists of 10 items scored on a four-point Likert scale, with total scores ranging from 10 to 40 and categorized as low (10-20), moderate (21-30), or high (31-40) self-esteem. The GAD-7 consists of seven items scored from 0 to 3, with total scores ranging from 0 to 21 and categorized as minimal (0-4), mild (5-9), moderate (10-14), or severe (≥15) anxiety. The CIPS consists of 20 items scored on a five-point Likert scale, with total scores ranging from 20 to 100 and categorized as none or minimal (≤40), moderate (41-60), frequent (61-80), or intense (>80) imposter syndrome.

STATISTICAL ANALYSIS:

Analyses were performed using IBM SPSS Statistics version 25.0 and R version 4.6.1. Internal consistency was assessed with Cronbach's alpha. Because most continuous variables were non-normally distributed, descriptive data used medians and interquartile ranges. Spearman's rank correlations and Mann-Whitney U tests with rank-biserial correlations were applied for bivariate analyses. GPA-related analyses used 423 complete cases after listwise deletion of 15 observations with missing GPA values. Simultaneous ordinary least-squares regression, hierarchical regression, Huber M-estimation, and median quantile regression were conducted. For the primary OLS regression coefficients, estimates used 5,000 bias-corrected and accelerated (BCa) bootstrap resamples (seed = 123). For Huber M-estimation, P-values were derived from the asymptotic normal approximation to robust test statistics. For median quantile regression (τ = 0.50), P-values were calculated using XY-bootstrap standard errors from 5,000 resamples (seed = 123). Model diagnostics assessed residual normality, homoscedasticity, multicollinearity, residual independence, and influential observations. Statistical significance was set at p < 0.05. Adequacy of the analytic sample was benchmarked using Green's sample-size heuristic (N ≥ 50 + 8k), requiring 130 for ten predictors; the complete-case sample (N = 423) exceeded this benchmark.

Being tested
Self-Report Questionnaire Assessment
Keywords
imposter syndrome, Anxiety, Students, Sleep, Cross-Sectional Studies, Indonesia, Universities
Medical subject headings
Anxiety Disorders, imposter syndrome

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Self-Report Questionnaire AssessmentOther

    Also called Clance Impostor Phenomenon Scale (CIPS; 20 items); Rosenberg Self-Esteem Scale (RSES; 10 items); Generalized Anxiety Disorder-7 (GAD-7; 7 items)

    Participants completed a structured battery of validated self-report questionnaires via a mixed paper-based (completed in class or within 48 hours) and online administration, not a single supervised classroom sitting as planned. The CIPS evaluated cognitive and affective features of impostorism; the RSES measured global self-esteem; and the Indonesian-adapted GAD-7 assessed anxiety symptom severity over the preceding two weeks. Additional self-reported items captured behavioral characteristics (nightly sleep duration and daily social media usage) alongside demographic and structural information (sex, age, cumulative GPA, scholarship status, residential arrangement, and organizational participation). No therapeutic, pharmacological, behavioral, or educational intervention was administered. Data collection was observational and cross-sectional in nature, with no manipulation of variables, experimental conditions, or intervention assignment.

Study groups in NCT07725302
Study groupRoleWhat they receive
Indonesian Sports Science UndergraduatesSports science undergraduates (semesters 3-4) at a public state university in Makassar, South Sulawesi, Indonesia, recruited from June to August 2025 (n = 438 analyzed out of 469 invited; response rate 93.4%). Participants completed a single-session, self-administered survey battery assessing psychological constructs-the CIPS, RSES, and GAD-7-alongside continuous behavioral measures (nightly sleep duration and daily social media usage) and self-reported demographic/institutional covariates (GPA, sex, age, scholarship recipiency, residential status, and organizational participation). No intervention was administered. This cross-sectional study evaluated the psychological correlates of the imposter syndrome among Indonesian sports science undergraduates, focusing specifically on the relative contributions of self-esteem and anxiety alongside related psychological, behavioral, and institutional factors.
Receives: Other: Self-Report Questionnaire Assessment

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Association Between Self-Esteem and Imposter Syndrome

    Spearman rank-order correlation coefficient (rho) evaluating the relationship between total global self-esteem scores assessed via the 10-item RSES (score range: 10-40, where higher scores indicate higher self-esteem) and total Imposter Syndrome severity scores measured using the 20-item CIPS (score range: 20-100, where higher scores denote greater impostorism severity) among sports science undergraduates. A negative correlation indicates higher self-esteem is associated with lower Imposter Syndrome severity.

    Measured: Single time point baseline assessment (June to August 2025)

  2. Association Between Anxiety Symptoms and Imposter Syndrome

    Spearman rank-order correlation coefficient (rho) evaluating the relationship between total anxiety symptom scores assessed via GAD-7 (score range: 0-21, where higher scores reflect higher anxiety severity) and total imposter syndrome severity scores (CIPS; score range: 20-100). A positive correlation indicates higher anxiety symptomatology is associated with greater imposter syndrome severity.

    Measured: Single time point baseline assessment (June to August 2025)

Secondary outcomes (2)
  1. Psychological Correlates of Imposter Syndrome

    Standardized regression coefficients (β) and unstandardized coefficients (B) derived from simultaneous-entry multiple linear regression, robust regression (Huber M-estimation), median quantile regression, and hierarchical regression models predicting total CIPS scores. Evaluated domain-specific predictors include psychological factors (RSES self-esteem, GAD-7 anxiety), behavioral habits (nightly sleep duration in hours, daily social media usage in hours), and structural/demographic covariates (biological sex, cumulative GPA, age, scholarship status, residential status, and organizational participation). Total explained variance (R², adjusted R²) and domain-specific incremental variance contributions (ΔR²) are reported.

    Measured: Single time point baseline assessment (June to August 2025)

  2. Demographic and Structural Differences in Imposter Syndrome Scores

    Between-group comparisons of total CIPS scores across categorical demographic and structural subgroups (biological sex [male vs. female], scholarship status [recipient vs. non-recipient], residential arrangement [living with family vs. dormitory], and organizational participation [active vs. non-active]) evaluated using Mann-Whitney U tests, with effect sizes quantified using rank-biserial correlations (r rb). Higher rank scores indicate higher levels of reported imposter syndrome within specific subgroups.

    Measured: Single time point baseline assessment (June to August 2025)

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Jul 2026
  2. Study start1 Jun 2025
  3. Primary completion31 Aug 2025
  4. Study completion31 Aug 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
438 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07725302
Sponsor's protocol ID
DURMAN-IMPOSTOR25
Other IDs
PPDS-PSY-UNHAS-2025
Acronym
IMPOSTOR-2025
Status last verified
Sep 2026
First submitted
21 Jul 2026
Last updated
11 Sep 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Individual participant data (IPD) will not be shared publicly or upon request to protect participant privacy and confidentiality, as explicit consent for secondary data sharing by third parties was not obtained during the ethical approval and informed consent process. De-identified summary statistics and aggregate data are fully presented within the manuscript and supporting information.

Questions about this trial

What is this clinical trial studying?

An observational study of Self Esteem and Anxiety, run by Hasanuddin University at 1 site in Indonesia.

The full registered description is in the About this study section and the official record.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 11 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Indonesia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Association Between Self-Esteem and Imposter Syndrome (time frame: Single time point baseline assessment (June to August 2025)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Sep 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in